Biomarkers refer to genes, molecules or certain characteristics enabling to evaluate or measure pharmacologic response to therapeutic treatment, or various pathogenic or biological processes. Categorized by their utilization in different medical procedures, biomarkers facilitate decision-taking in early clinical drug development, thus helping to detect a patient’s health state. Oncology belongs within the major diseases where biomarkers are widely used.
Supported by novel product’s introductions, fresh market entrants, as well as M&As and other related activities, the world Biomarkers Market is evolving at a colossal tempo, set to be ultimately valued at just over EUR 26 billion by end-2018. Novel technologies exploited for biomarker discovery are the foremost contributors to the Biomarkers sector. North America heads the market as the most speedily growing geographic area. Major Biomarkers Market participants encompass, among others, Abbot Laboratories, Affymetrix, Agilent, Epigenomics, Celera, GE Healthcare, and DiagnoCure.
The research reports under this MarketPublishers’ Catalogue delve deep into the Biomarkers Market and its major submarkets – discovery technologies, services market, application market, and various indications. Covering various geographies, the research reports identify and examine the principal trends, opportunities, and the factors propelling or clogging the market growth. The competitive landscape with comprehensive profiles of numerous players in the global Biomarkers Industry, forecasts throwing light on the market’s future are provided in the research reports too.
Publications found:
105
Sort by:
Cancer Biomarkers Market Report by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics), Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, and Others), Application (Diagnostics, Prognostics, Risk Assessment, Drug Discovery and Development, and Others), End User (Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Region 2026-2034
US$ 3,999.00
The global cancer biomarkers market size reached USD 34.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 91.2 Billion by 2034, exhibiting a growth rate (CAGR) of 10.97%...
June 2026
145 pages
Vocal Biomarker Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technique (Frequency, Amplitude, Error Rate, Vocal Rise or Fall Time, Phonation Time, Vocal Tremor, Pitch, Others), By Indication (Psychiatric Disorders, Respiratory Disorders, Cardiovascular Disorders, Traumatic Brain Injury (TBI), Neurological disorders, Other), By End-User (Hospitals & Clinics, Ambulatory care Centers, Others) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Vocal Biomarker Market is projected to expand significantly, from USD 2.11 Billion in 2025 to USD 3.61 Billion by 2031, demonstrating a compound annual growth rate (CAGR) of 9.36%. Vocal bi...
May 2026
180 pages
Neurological Biomarkers Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type (Imaging, Proteomic, Genomic, Metabolomic, Others), By Application (Multiple Sclerosis, Alzheimer's Disease, Autism Spectrum Disorder, Parkinson's Disease, Others), By End-User (Research Organizations, Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Neurological Biomarkers Market is projected to expand significantly, rising from USD 8.81 Billion in 2025 to USD 14.12 Billion by 2031, demonstrating an 8.18% Compound Annual Growth Rate. N...
May 2026
185 pages
Alzheimers Disease Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (CSF Biomarkers, Amyloid Beta, Tau Protein, Genetic Biomarkers, Apolipoprotein E, Blood Biomarkers, Others), By Detection Technique (Molecular Diagnostics, Immunoassays), By End user (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Alzheimer’s Disease Biomarkers Market is projected to expand from USD 0.91 Billion in 2025 to USD 1.43 Billion by 2031, reflecting a compound annual growth rate of 7.82%. These biomarkers f...
May 2026
185 pages
Cancer Biomarkers Market by Profiling Technology (Omics, Imaging), Cancer (Lung, Breast, Leukemia, Melanoma), Product (Instruments, Consumables), Application (Diagnostics, R&D), End User (Diagnostic Laboratories), And Region - Global Forecast to 2032
US$ 7,150.00
... factors expected to restrain the market. “The lung cancer segment is expected to register the highest CAGR’ The cancer biomarkers market on the basis of cancer type is classified into breast ...
May 2026
468 pages
Biomarker Technologies Market Report by Test Type (Solid Biopsy, Liquid Biopsy), Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, and Others), Product (Consumables, Assay, Reagent, Instruments), Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunoassay, and Others), Application (Drug Discovery, Clinical Diagnostics, Personalized Medicine), and Region 2026-2034
US$ 3,999.00
The global biomarker technologies market size reached USD 50.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 129.4 Billion by 2034, exhibiting a growth rate (CAGR) of 1...
April 2026
141 pages
Global Cardiac Biomarkers Market - 2025-2033
US$ 2,999.00
The Global Cardiac Biomarkers Market was valued at US$ 25.20 billion in 2025 and is anticipated to reach US$ 73.28 billion by 2033, at a CAGR of 0.1322 from 2026 to 2032. The report delivers in-depth...
March 2026
223 pages
Cardiac Biomarkers Market Size, Share & Trends Analysis Report By Type (Troponin, Creatine kinase - MB (CK-MB), Myoglobin, BNP and NT-proBNP), By Application (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure), By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global cardiac biomarkers market size was estimated at USD 20.81 billion in 2025 and is expected to reach USD 49.31 billion by 2033, growing at a CAGR of 11.5% from 2026 to 2033. The market is dri...
February 2026
130 pages
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets
US$ 4,650.00
... report provides a comprehensive analysis of CNS biomarkers on a global basis. Its aim is to provide a range of information, from detailed product analyses within disease ... sub segments to overall industry trends, in order to quantify and qualify the market for products and services in the CNS biomarkers ...
February 2026
172 pages
Genomic Biomarker Market 2026
US$ 2,999.00
The Genomic Biomarker Market was valued at in and is anticipated to reach by , at a CAGR of 0.15 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional g...
January 2026
218 pages
Renal Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Functional Biomarker, Serum Creatinine, Serum Cystatin C, Urine Albumin, Up-regulated Protein, Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecule-1, INTERLEUKIN-18, Others), By Technique (Enzyme-linked Immunosorbent Assay (ELISA), Particle-enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LC-MS)), By End user (Hospitals & Clinics, Diagnostic Laboratory, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Renal Biomarkers Market is projected to expand from USD 1.41 Billion in 2025 to USD 2.15 Billion by 2031, reflecting a compound annual growth rate of 7.28%. Renal biomarkers, which are meas...
January 2026
186 pages
Personalized Medicine Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Early Detection/Screening, Indication, Treatment Selection, Monitoring), By Indication (Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Personalized Medicine Biomarkers Market is projected to expand from USD 15.99 Billion in 2025 to USD 23.34 Billion by 2031, reflecting a CAGR of 6.51%. These biomarkers, which include speci...
January 2026
186 pages
Cardiac Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Troponin, CK-MB, Myoglobin, BNP and NT-proBNP, Others), By Application (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cardiac Biomarkers Market is projected to expand from USD 18.41 Billion in 2025 to USD 29.23 Billion by 2031, registering a CAGR of 8.01%. These biomarkers, consisting of measurable enzymes...
January 2026
180 pages
PARP Inhibitor Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Kits, Assays), By Services (BRCA 1 & 2 Testing, HRD Testing, HRR Testing, Others), By Application (Breast Cancer, Ovarian Cancer, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global PARP Inhibitor Biomarkers Market is projected to expand from USD 942.14 Million in 2025 to USD 1563.61 Million by 2031, achieving a CAGR of 8.81%. These biomarkers, which encompass specific...
January 2026
180 pages
Blood-based Biomarker For Sports Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Blood-based Biomarker For Sports Medicine Market is projected to increase from USD 813.12 Million in 2025 to USD 1163.91 Million by 2031, registering a CAGR of 6.16%. These biomarkers funct...
January 2026
185 pages
Troponin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Troponin I, Troponin T, Troponin Complex, Others), By Application (Myocardial Infarction, Acute Coronary Syndrome, Congestive Heart Failure, Cardiomyopathy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Troponin Market is projected to expand from USD 2.12 Billion in 2025 to USD 3.21 Billion by 2031, registering a CAGR of 7.16%. This market is characterized by the diagnostic necessity for s...
January 2026
180 pages
Biomarker Testing Market 2026
US$ 2,999.00
The Biomarker Testing Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gr...
January 2026
219 pages
The 2027-2032 World Outlook for Cardiac Biomarkers
US$ 1,195.00
This study covers the world outlook for cardiac biomarkers across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for cardiac biomarkers. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Biomarker Systems
US$ 1,195.00
This study covers the world outlook for biomarker systems across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for biomarker systems. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Cancer Biomarkers
US$ 1,195.00
This study covers the world outlook for cancer biomarkers across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for cancer biomarkers. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
289 pages
The 2027-2032 World Outlook for 2D in Vitro Lung Models
US$ 1,195.00
This study covers the world outlook for 2D in vitro lung models across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Bio-Lubricant
US$ 1,195.00
This study covers the world outlook for bio-lubricant across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th...
January 2026
287 pages
The 2027-2032 World Outlook for Biomarker Technologies
US$ 1,195.00
This study covers the world outlook for biomarker technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Carcinoembryonic Antigen
US$ 1,195.00
This study covers the world outlook for carcinoembryonic antigen across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Liver Organs-on-Chips
US$ 1,195.00
This study covers the world outlook for liver organs-on-chips across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Neurological Biomarkers
US$ 1,195.00
This study covers the world outlook for neurological biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Renal Biomarkers
US$ 1,195.00
This study covers the world outlook for renal biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
Global Cancer Biomarker Testing Market - 2023-2033
US$ 2,999.00
The Global Cancer Biomarker Testing Market was valued at US$ 29.83 Billion in 2023 and is anticipated to reach US$ 96.53 Billion by 2033, at a CAGR of 0.126 from 2026 to 2032. The report delivers in-d...
December 2025
217 pages
Immunoassay for Neurological Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Instruments, Reagents, Services), By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Others), By Application (In Vitro Diagnostics, Research), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Immunoassay for Neurological Biomarkers Market, valued at USD 654.22 Million in 2024, is projected to experience a CAGR of 11.65% to reach USD 1267.29 Million by 2030. Immunoassays for neur...
November 2025
185 pages
Biomarker Discovery Market - 2023-2033
US$ 2,999.00
The Biomarker Discovery Market was valued at US$ 17.84 Billion in 2023 and is anticipated to reach US$ 54.19 Billion by 2033, at a CAGR of 0.119 from 2026 to 2032. The report delivers in-depth insight...
November 2025
223 pages
Carcinoembryonic Antigen (CEA) Market 20262040
US$ 2,999.00
The Carcinoembryonic Antigen (CEA) Market was valued at in and is anticipated to reach 29.5 million by 2040, at a CAGR of 0.039 from 2026 to 2032. The report delivers in-depth insights into key market...
November 2025
219 pages
Digital Biomarkers in Oncology Clinical Trails Market 2026
US$ 2,999.00
The Digital Biomarkers in Oncology Clinical Trails Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dy...
November 2025
220 pages
Prostate Cancer Biomarker Market 2026
US$ 2,999.00
The Prostate Cancer Biomarker Market was valued at in and is anticipated to reach by , at a CAGR of 0.1261 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
November 2025
207 pages
Renal Biomarkers Market 2026
US$ 2,999.00
The Renal Biomarkers Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gro...
November 2025
207 pages
Global Biosensor System Market Growth 2025-2031
US$ 3,660.00
... the global market share (sales and revenue) of key companies in Biosensor System business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Biosensor System market ...
November 2025
122 pages
Global Biochemical Sensor Market Growth 2025-2031
US$ 3,660.00
The global Biochemical Sensor market size is predicted to grow from US$ 25100 million in 2025 to US$ 43370 million in 2031; it is expected to grow at a CAGR of 9.5% from 2025 to 2031. The impact of th...
November 2025
138 pages
Global Biochemical Sensors Market Growth 2025-2031
US$ 3,660.00
The global Biochemical Sensors market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. t...
November 2025
163 pages
Global Bioelectronics and Biosensors Market Growth 2025-2031
US$ 3,660.00
The global Bioelectronics and Biosensors market size is predicted to grow from US$ 19180 million in 2025 to US$ 34670 million in 2031; it is expected to grow at a CAGR of 10.4% from 2025 to 2031. The...
November 2025
100 pages
Global Bioacoustics Sensor Market Growth 2025-2031
US$ 3,660.00
The global Bioacoustics Sensor market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. t...
November 2025
101 pages
Global Bioacoustics Sensor System Market Growth 2025-2031
US$ 3,660.00
The global Bioacoustics Sensor System market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest...
November 2025
91 pages
